By Galen Care Partners on Tuesday, 13 June 2017
Category: Galen Care Partners News

Canagliflozin Lowers Cardiovascular Risks in Type 2 Diabetes Patients

Study findings suggest that the medication may offer renal protection.
Original link
Leave Comments